Showing results (1581-1590 of 1,811) with videos related to

Sort By:
Pageof 182
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2021
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint InhibitorsFyza Y Shaikh, James R White, Joell J Gills, et al.
Cancer Research|February 26, 2017
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer PathogenesisRyan J Hartmaier, Lee A Albacker, Juliann Chmielecki, et al.
Elife|June 28, 2013
Evolutionary dynamics of cancer in response to targeted combination therapyIvana Bozic, Johannes G Reiter, Benjamin Allen, et al.
Oncoscience|August 6, 2015
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplificationUmut Disel, Alexis Germain, Bahar Yilmazel, et al.
American Journal of Epidemiology|March 14, 2019
Reproductive Factors and Mammographic Density: Associations Among 24,840 Women and Comparison of Studies Using Digitized Film-Screen Mammography and Full-Field Digital MammographyStacey E Alexeeff, Nnaemeka U Odo, Russell McBride, et al.
Familial Cancer|May 29, 2012
Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutationsMonique A de Bruin, Ava Kwong, Benjamin A Goldstein, et al.
Radiologic Clinics of North America|February 8, 2005
Hyperpolarized helium-3 MR imaging of pulmonary functionMasaru Ishii, Martin C Fischer, Kiarash Emami, et al.
Cancer|December 10, 2015
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterationsJeffrey S Ross, Kai Wang, Depinder Khaira, et al.
Bioorganic & Medicinal Chemistry|June 16, 2009
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonistsRonald C Bernotas, Steven Lenicek, Schuyler Antane, et al.
Breast Cancer Research and Treatment|October 30, 2013
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer riskShaveta Vinayak, Erich J Schwartz, Kristin Jensen, et al.
Pageof 182